Paul A. Gendron - May 17, 2022 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Director
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Paul A. Gendron
Stock symbol
INFU
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 05:08 PM
Previous filing
Feb 15, 2022
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INFU Common Stock 60K May 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFU Stock Option (right to buy) Award $0 +25K $0.00 25K May 17, 2022 Common Stock 25K $8.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.
F2 The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting.